Current Issue : April-June Volume : 2025 Issue Number : 2 Articles : 1 Articles
Cellulitis is a non-necrotising condition characterised by inflammation of the skin's dermis and subcutaneous layers, commonly resulting from an acute bacterial infection. Antimicrobial resistance poses a significant challenge to public health, highlighting the need to evaluate treatment patterns. The study was aimed to assess the clinical profile and antimicrobial prescribing patterns among cellulitis patients at Navodaya Medical College Hospital and Research Center (NMCH & RC), Raichur, Karnataka, India. This retrospective, observational study was conducted over six months (15th February 2024 to 15th August 2024) which included 90 cellulitis patients. The mean age was 50.5 years, with 74.44% males and 25.56% females. Swelling was the most frequent symptom (92.22%), followed by pain (47.77%) and fever (18.88%). Comorbidities were present in 60% of patients, with hypertension (26.66%) and diabetes mellitus (16.66%) being the most common. The majority (46.67%) of patients had a hospital stay of 1-5 days. Metronidazole was the most frequently prescribed antibiotic (66.66%), followed by the combination of Amoxicillin and Clavulanate (34.44%). Nitroimidazoles were the most common class of antibiotics used. Additionally, pantoprazole (94.44%) and paracetamol (62.22%) were commonly prescribed to manage symptoms, with diclofenac (46.66%) also used for pain and inflammation. Both Access and Watch category antibiotics from the WHO’s AWaRe classification were commonly prescribed. Metronidazole and Amoxicillin + Clavulanic acid, from the Access group, were frequently used, Watch antibiotics such as Amikacin and Ceftriaxone were also prescribed. To prevent antibiotic misuse, standard treatment guidelines are necessary....
Loading....